{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:03:48Z","timestamp":1789974228334,"version":"4.0.1"},"reference-count":214,"publisher":"China Science Publishing & Media Ltd.","issue":"9","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.3724\/abbs.2026130","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:09:14Z","timestamp":1783933754000},"page":"1915-1930","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic endotoxemia in metabolic and neurodegenerative diseases"],"prefix":"10.3724","volume":"58","author":[{"given":"Changshun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41580-020-0278-0","volume":"22","author":"Beumer J","year":"2021","unstructured":"Beumer J, Clevers H. Cell fate specification and differentiation in the adult mammalian intestine. Nat Rev Mol Cell Biol, 2021, 22: 39-53.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1152\/physrev.00045.2009","volume":"90","author":"Sekirov I","year":"2010","unstructured":"Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol Rev, 2010, 90: 859-904.","journal-title":"Physiol Rev"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/10408363.2015.1123215","volume":"53","author":"Gnauck A","year":"2016","unstructured":"Gnauck A, Lentle RG, Kruger MC. Chasing a ghost? Issues with the determination of circulating levels of endotoxin in human blood. Crit Rev Clin Lab Sci, 2016, 53: 197-215.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/ajcn\/86.5.1286","volume":"86","author":"Erridge C","year":"2007","unstructured":"Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr, 2007, 86: 1286-1292.","journal-title":"Am J Clin Nutr"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"Ni J","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation?. Nat Rev Gastroenterol Hepatol, 2017, 14: 573-584.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","volume":"15","author":"Ananthakrishnan AN","year":"2018","unstructured":"Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol, 2018, 15: 39-49.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"e70566","DOI":"10.1096\/fj.202500310R","volume":"39","author":"Gan L","year":"2025","unstructured":"Gan L, Yu CY, Chen J, Zou B, Xiao Z, Jiang W, Li D. Acyloxyacyl hydrolase prevents colitis and colitis-associated colorectal cancer by inactivating stimulatory LPS in the intestine. FASEB J, 2025, 39:","journal-title":"FASEB J"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1016\/j.ajpath.2017.08.005","volume":"187","author":"Nighot M","year":"2017","unstructured":"Nighot M, Al-Sadi R, Guo S, Rawat M, Nighot P, Watterson MD, Ma TY. Lipopolysaccharide-induced increase in intestinal epithelial tight permeability is mediated by toll-like receptor 4\/Myeloid differentiation primary response 88 (MyD88) activation of myosin light chain kinase expression. Am J Pathol, 2017, 187: 2698-2710.","journal-title":"Am J Pathol"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"Cani PD","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 2007, 56: 1761-1772.","journal-title":"Diabetes"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.3390\/ijms25137006","volume":"25","author":"Chmielarz M","year":"2024","unstructured":"Chmielarz M, Sobieszcza\u0144ska B, \u015aroda-Pomianek K. Metabolic endotoxemia: from the gut to neurodegeneration. Int J Mol Sci, 2024, 25:","journal-title":"Int J Mol Sci"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","volume":"71","author":"Raetz CRH","year":"2002","unstructured":"Raetz CRH, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem, 2002, 71: 635-700.","journal-title":"Annu Rev Biochem"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1286-4579(02)01604-0","volume":"4","author":"Erridge C","year":"2002","unstructured":"Erridge C, Bennett-Guerrero E, Poxton IR. Structure and function of lipopolysaccharides. Microbes Infect, 2002, 4: 837-851.","journal-title":"Microbes Infect"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1128\/CDLI.12.1.60-67.2005","volume":"12","author":"Copeland S","year":"2005","unstructured":"Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D. Acute inflammatory response to endotoxin in mice and humans. Clin Vaccine Immunol, 2005, 12: 60-67.","journal-title":"Clin Vaccine Immunol"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/08830185.2017.1280483","volume":"36","author":"Faraj TA","year":"2017","unstructured":"Faraj TA, McLaughlin CL, Erridge C. Host defenses against metabolic endotoxaemia and their impact on lipopolysaccharide detection. Int Rev Immunol, 2017, 36: 125-144.","journal-title":"Int Rev Immunol"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","volume":"180","author":"Fitzgerald KA","year":"2020","unstructured":"Fitzgerald KA, Kagan JC. Toll-like receptors and the control of immunity. Cell, 2020, 180: 1044-1066.","journal-title":"Cell"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"Takeuchi O","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell, 2010, 140: 805-820.","journal-title":"Cell"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1172\/JCI118110","volume":"96","author":"Cross A","year":"1995","unstructured":"Cross A, Asher L, Seguin M, Yuan L, Kelly N, Hammack C, Sadoff J.  The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli . J Clin Invest, 1995, 96: 676-686.","journal-title":"J Clin Invest"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1128\/IAI.68.5.2410-2417.2000","volume":"68","author":"Vesy CJ","year":"2000","unstructured":"Vesy CJ, Kitchens RL, Wolfbauer G, Albers JJ, Munford RS. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from Gram-negative bacterial membranes. Infect Immun, 2000, 68: 2410-2417.","journal-title":"Infect Immun"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1084\/jem.164.3.777","volume":"164","author":"Tobias PS","year":"1986","unstructured":"Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med, 1986, 164: 777-793.","journal-title":"J Exp Med"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1084\/jem.179.1.269","volume":"179","author":"Hailman E","year":"1994","unstructured":"Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med, 1994, 179: 269-277.","journal-title":"J Exp Med"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1126\/science.1698311","volume":"249","author":"Wright SD","year":"1990","unstructured":"Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science, 1990, 249: 1431-1433.","journal-title":"Science"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ni809","volume":"3","author":"Nagai Y","year":"2002","unstructured":"Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol, 2002, 3: 667-672.","journal-title":"Nat Immunol"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/nature07830","volume":"458","author":"Park BS","year":"2009","unstructured":"Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature, 2009, 458: 1191-1195.","journal-title":"Nature"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"e31377","DOI":"10.7554\/eLife.31377","volume":"7","author":"Latty SL","year":"2018","unstructured":"Latty SL, Sakai J, Hopkins L, Verstak B, Paramo T, Berglund NA, Cammarota E. Activation of Toll-like receptors nucleates assembly of the MyDDosome signaling hub. eLife, 2018, 7:","journal-title":"eLife"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ni1569","volume":"9","author":"Kagan JC","year":"2008","unstructured":"Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of toll-like receptor 4 to the induction of interferon-\u03b2. Nat Immunol, 2008, 9: 361-368.","journal-title":"Nat Immunol"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cell.2011.09.051","volume":"147","author":"Zanoni I","year":"2011","unstructured":"Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F. CD14 controls the LPS-induced endocytosis of toll-like receptor 4. Cell, 2011, 147: 868-880.","journal-title":"Cell"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature13157","volume":"509","author":"Meunier E","year":"2014","unstructured":"Meunier E, Dick MS, Dreier RF, Sch\u00fcrmann N, Broz DK, Warming S, Roose-Girma M. Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature, 2014, 509: 366-370.","journal-title":"Nature"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2016.04.015","volume":"165","author":"Vanaja SK","year":"2016","unstructured":"Vanaja SK, Russo AJ, Behl B, Banerjee I, Yankova M, Deshmukh SD, Rathinam VAK. Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation. Cell, 2016, 165: 1106-1119.","journal-title":"Cell"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/s41556-023-01269-8","volume":"25","author":"Kumari P","year":"2023","unstructured":"Kumari P, Vasudevan SO, Russo AJ, Wright SS, Fraile-\u00c1greda V, Krajewski D, Jellison ER. Host extracellular vesicles confer cytosolic access to systemic LPS licensing non-canonical inflammasome sensing and pyroptosis. Nat Cell Biol, 2023, 25: 1860-1872.","journal-title":"Nat Cell Biol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature13683","volume":"514","author":"Shi J","year":"2014","unstructured":"Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature, 2014, 514: 187-192.","journal-title":"Nature"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1126\/science.1240988","volume":"341","author":"Hagar JA","year":"2013","unstructured":"Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science, 2013, 341: 1250-1253.","journal-title":"Science"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/science.1240248","volume":"341","author":"Kayagaki N","year":"2013","unstructured":"Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science, 2013, 341: 1246-1249.","journal-title":"Science"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","volume":"186","author":"Barnett KC","year":"2023","unstructured":"Barnett KC, Li S, Liang K, Ting JPY. A 360\u00b0 view of the inflammasome: Mechanisms of activation, cell death, and diseases. Cell, 2023, 186: 2288-2312.","journal-title":"Cell"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"Swanson KV","year":"2019","unstructured":"Swanson KV, Deng M, Ting JPY. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol, 2019, 19: 477-489.","journal-title":"Nat Rev Immunol"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41577-024-00995-w","volume":"24","author":"Fu J","year":"2024","unstructured":"Fu J, Schroder K, Wu H. Mechanistic insights from inflammasome structures. Nat Rev Immunol, 2024, 24: 518-535.","journal-title":"Nat Rev Immunol"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"Kayagaki N","year":"2015","unstructured":"Kayagaki N, Stowe IB, Lee BL, O\u2019Rourke K, Anderson K, Warming S, Cuellar T. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature, 2015, 526: 666-671.","journal-title":"Nature"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1084\/jem.20180589","volume":"215","author":"Lee BL","year":"2018","unstructured":"Lee BL, Stowe IB, Gupta A, Kornfeld OS, Roose-Girma M, Anderson K, Warming S. Caspase-11 auto-proteolysis is crucial for noncanonical inflammasome activation. J Exp Med, 2018, 215: 2279-2288.","journal-title":"J Exp Med"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"Shi J","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature, 2015, 526: 660-665.","journal-title":"Nature"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1002\/eji.201545655","volume":"45","author":"Baker PJ","year":"2015","unstructured":"Baker PJ, Boucher D, Bierschenk D, Tebartz C, Whitney PG, D\u2032Silva DB, Tanzer MC. NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5. Eur J Immunol, 2015, 45: 2918-2926.","journal-title":"Eur J Immunol"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/eji.201545772","volume":"45","author":"R\u00fchl S","year":"2015","unstructured":"R\u00fchl S, Broz P.  Caspase-11 activates a canonical NLRP3 inflammasome by promoting K+ efflux . Eur J Immunol, 2015, 45: 2927-2936.","journal-title":"Eur J Immunol"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41590-023-01526-w","volume":"24","author":"Devant P","year":"2023","unstructured":"Devant P, Kagan JC. Molecular mechanisms of gasdermin D pore-forming activity. Nat Immunol, 2023, 24: 1064-1075.","journal-title":"Nat Immunol"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.immuni.2023.03.003","volume":"56","author":"Zhu F","year":"2023","unstructured":"Zhu F, Ma J, Li W, Liu Q, Qin X, Qian Y, Wang C. The orphan receptor Nur77 binds cytoplasmic LPS to activate the non-canonical NLRP3 inflammasome. Immunity, 2023, 56: 753-767.e8.","journal-title":"Immunity"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1128\/jb.166.3.699-705.1986","volume":"166","author":"Hitchcock PJ","year":"1986","unstructured":"Hitchcock PJ, Leive L, M\u00e4kel\u00e4 PH, Rietschel ET, Strittmatter W, Morrison DC. Lipopolysaccharide nomenclature\u2014past, present, and future. J Bacteriol, 1986, 166: 699-705.","journal-title":"J Bacteriol"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1371\/journal.ppat.0020067","volume":"2","author":"Munford RS","year":"2006","unstructured":"Munford RS, Varley AW. Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria. PLoS Pathog, 2006, 2:","journal-title":"PLoS Pathog"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1189\/jlb.3RU0316-151R","volume":"100","author":"Munford RS","year":"2016","unstructured":"Munford RS. Endotoxemia\u2014menace, marker, or mistake?. J Leukoc Biol, 2016, 100: 687-698.","journal-title":"J Leukoc Biol"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1096\/fasebj.8.2.8119492","volume":"8","author":"Rietschel ET","year":"1994","unstructured":"Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB Journal, 1994, 8: 217-225.","journal-title":"FASEB Journal"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","volume":"130","author":"Kim HM","year":"2007","unstructured":"Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, Enkhbayar P. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran. Cell, 2007, 130: 906-917.","journal-title":"Cell"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrmicro3047","volume":"11","author":"Needham BD","year":"2013","unstructured":"Needham BD, Trent MS. Fortifying the barrier: the impact of lipid a remodelling on bacterial pathogenesis. Nat Rev Microbiol, 2013, 11: 467-481.","journal-title":"Nat Rev Microbiol"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"1588129","DOI":"10.3389\/fimmu.2025.1588129","volume":"16","author":"Tume R","year":"2025","unstructured":"Tume R, El Sherbiny S, Bono R, Gautier T, Pais de Barros JP, Mero\u00f1o T. The balance between proinflammatory, \u201cbad\u201d, and immunomodulatory, \u201cgood\u201d, lipopolysaccharide for understanding gut-derived systemic inflammation. Front Immunol, 2025, 16:","journal-title":"Front Immunol"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"8395","DOI":"10.3390\/ijms24098395","volume":"24","author":"Fux AC","year":"2023","unstructured":"Fux AC, Casonato Melo C, Michelini S, Swartzwelter BJ, Neusch A, Italiani P, Himly M. Heterogeneity of lipopolysaccharide as source of variability in bioassays and LPS-binding proteins as remedy. Int J Mol Sci, 2023, 24:","journal-title":"Int J Mol Sci"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"e00046-17","DOI":"10.1128\/mSystems.00046-17","volume":"2","author":"d\u2019Hennezel E","year":"2017","unstructured":"d\u2019Hennezel E, Abubucker S, Murphy LO, Cullen TW, Lozupone C. Total lipopolysaccharide from the human gut microbiome silences toll-like receptor signaling. mSystems, 2017, 2:","journal-title":"mSystems"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.cell.2016.05.056","volume":"165","author":"Vatanen T","year":"2016","unstructured":"Vatanen T, Kostic AD, d\u2019Hennezel E, Siljander H, Franzosa EA, Yassour M, Kolde R. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell, 2016, 165:","journal-title":"Cell"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"109691","DOI":"10.1016\/j.celrep.2021.109691","volume":"36","author":"Anh\u00ea FF","year":"2021","unstructured":"Anh\u00ea FF, Barra NG, Cavallari JF, Henriksbo BD, Schertzer JD. Metabolic endotoxemia is dictated by the type of lipopolysaccharide. Cell Rep, 2021, 36:","journal-title":"Cell Rep"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0005-2736(89)90351-9","volume":"984","author":"Victorov AV","year":"1989","unstructured":"Victorov AV, Medvedeva NV, Gladkaya EM, Morozkin AD, Podrez EA, Kosykh VA, Yurkiv VA.  Composition and structure of lipopolysaccharide-human plasma low density lipoprotein complex. Analytical ultracentrifugation, 31P-NMR, ESR and fluorescence spectroscopy studies . Biochim Biophys Acta, 1989, 984: 119-127.","journal-title":"Biochim Biophys Acta"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"12172","DOI":"10.1074\/jbc.271.21.12172","volume":"271","author":"Hailman E","year":"1996","unstructured":"Hailman E, Albers JJ, Wolfbauer G, Tu AY, Wright SD. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J Biol Chem, 1996, 271: 12172-12178.","journal-title":"J Biol Chem"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.180.3.1025","volume":"180","author":"Wurfel MM","year":"1994","unstructured":"Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med, 1994, 180: 1025-1035.","journal-title":"J Exp Med"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1128\/IAI.69.5.2821-2828.2001","volume":"69","author":"Levels JHM","year":"2001","unstructured":"Levels JHM, Abraham PR, van den Ende A, van Deventer SJH. Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun, 2001, 69: 2821-2828.","journal-title":"Infect Immun"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/AAC.44.3.504-510.2000","volume":"44","author":"Rose JR","year":"2000","unstructured":"Rose JR, Mullarkey MA, Christ WJ, Hawkins LD, Lynn M, Kishi Y, Wasan KM. Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins. Antimicrob Agents Chemother, 2000, 44: 504-510.","journal-title":"Antimicrob Agents Chemother"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"34116","DOI":"10.1074\/jbc.274.48.34116","volume":"274","author":"Kitchens RL","year":"1999","unstructured":"Kitchens RL, Wolfbauer G, Albers JJ, Munford RS. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem, 1999, 274: 34116-34122.","journal-title":"J Biol Chem"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1172\/JCI200113139","volume":"108","author":"Kitchens RL","year":"2001","unstructured":"Kitchens RL, Thompson PA, Viriyakosol S, O\u2019Keefe GE, Munford RS. Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest, 2001, 108: 485-493.","journal-title":"J Clin Invest"},{"key":"CITATION61","doi-asserted-by":"publisher","first-page":"13726","DOI":"10.1074\/jbc.M609462200","volume":"282","author":"Shao B","year":"2007","unstructured":"Shao B, Lu M, Katz SC, Varley AW, Hardwick J, Rogers TE, Ojogun N. A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. J Biol Chem, 2007, 282: 13726-13735.","journal-title":"J Biol Chem"},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/hep.24488","volume":"54","author":"Shao B","year":"2011","unstructured":"Shao B, Kitchens RL, Munford RS, Rogers TE, Rockey DC, Varley AW. Prolonged hepatomegaly in mice that cannot inactivate bacterial endotoxin. Hepatology, 2011, 54: 1051-1062.","journal-title":"Hepatology"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1172\/JCI31539","volume":"118","author":"Cai L","year":"2008","unstructured":"Cai L, Ji A, de Beer FC, Tannock LR, van der Westhuyzen DR. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest, 2008, 118: 364-375.","journal-title":"J Clin Invest"},{"key":"CITATION64","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1194\/jlr.M007435","volume":"51","author":"Thompson PA","year":"2010","unstructured":"Thompson PA, Gauthier KC, Varley AW, Kitchens RL. ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance. J Lipid Res, 2010, 51: 2672-2685.","journal-title":"J Lipid Res"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.3529396","volume":"234","author":"Munford RS","year":"1986","unstructured":"Munford RS, Hall CL. Detoxification of bacterial lipopolysaccharides (Endotoxins) by a human neutrophil enzyme. Science, 1986, 234: 203-205.","journal-title":"Science"},{"key":"CITATION66","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.1073\/pnas.80.21.6671","volume":"80","author":"Hall CL","year":"1983","unstructured":"Hall CL, Munford RS.  Enzymatic deacylation of the lipid A moiety of Salmonella typhimurium lipopolysaccharides by human neutrophils . Proc Natl Acad Sci USA, 1983, 80: 6671-6675.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION67","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1084\/jem.20030420","volume":"197","author":"Lu M","year":"2003","unstructured":"Lu M, Zhang M, Kitchens RL, Fosmire S, Takashima A, Munford RS. Stimulus-dependent deacylation of bacterial lipopolysaccharide by dendritic cells. J Exp Med, 2003, 197: 1745-1754.","journal-title":"J Exp Med"},{"key":"CITATION68","doi-asserted-by":"publisher","first-page":"17842","DOI":"10.1074\/jbc.REV120.015254","volume":"295","author":"Munford RS","year":"2020","unstructured":"Munford RS, Weiss JP, Lu M. Biochemical transformation of bacterial lipopolysaccharides by acyloxyacyl hydrolase reduces host injury and promotes recovery. J Biol Chem, 2020, 295: 17842-17851.","journal-title":"J Biol Chem"},{"key":"CITATION69","doi-asserted-by":"publisher","first-page":"RP100731","DOI":"10.7554\/eLife.100731","volume":"13","author":"Wang Z","year":"2025","unstructured":"Wang Z, Ojogun N, Liu Y, Gan L, Xiao Z, Feng J, Jiang W. A host enzyme reduces metabolic dysfunction-associated steatotic liver disease (MASLD) by inactivating intestinal lipopolysaccharide. eLife, 2025, 13:","journal-title":"eLife"},{"key":"CITATION70","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1073\/pnas.1311987111","volume":"111","author":"Janelsins BM","year":"2014","unstructured":"Janelsins BM, Lu M, Datta SK. Altered inactivation of commensal LPS due to acyloxyacyl hydrolase deficiency in colonic dendritic cells impairs mucosal Th17 immunity. Proc Natl Acad Sci USA, 2014, 111: 373-378.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION71","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1128\/IAI.72.6.3171-3178.2004","volume":"72","author":"Feulner JA","year":"2004","unstructured":"Feulner JA, Lu M, Shelton JM, Zhang M, Richardson JA, Munford RS. Identification of acyloxyacyl hydrolase, a lipopolysaccharide-detoxifying enzyme, in the murine urinary tract. Infect Immun, 2004, 72: 3171-3178.","journal-title":"Infect Immun"},{"key":"CITATION72","doi-asserted-by":"publisher","first-page":"16444","DOI":"10.1016\/S0021-9258(17)46242-9","volume":"265","author":"Erwin AL","year":"1990","unstructured":"Erwin AL, Munford RS. Deacylation of structurally diverse lipopolysaccharides by human acyloxyacyl hydrolase. J Biol Chem, 1990, 265: 16444-16449.","journal-title":"J Biol Chem"},{"key":"CITATION73","doi-asserted-by":"publisher","first-page":"36579","DOI":"10.1074\/jbc.274.51.36579","volume":"274","author":"Katz SS","year":"1999","unstructured":"Katz SS, Weinrauch Y, Munford RS, Elsbach P, Weiss J.  Deacylation of lipopolysaccharide in whole Escherichia coli during destruction by cellular and extracellular components of a rabbit peritoneal inflammatory exudate . J Biol Chem, 1999, 274: 36579-36584.","journal-title":"J Biol Chem"},{"key":"CITATION74","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1128\/IAI.67.7.3376-3382.1999","volume":"67","author":"Weinrauch Y","year":"1999","unstructured":"Weinrauch Y, Katz SS, Munford RS, Elsbach P, Weiss J. Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate. Infect Immun, 1999, 67: 3376-3382.","journal-title":"Infect Immun"},{"key":"CITATION75","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.1074\/jbc.M605031200","volume":"282","author":"Gioannini TL","year":"2007","unstructured":"Gioannini TL, Teghanemt A, Zhang DS, Prohinar P, Levis EN, Munford RS, Weiss JP. Endotoxin-binding proteins modulate the susceptibility of bacterial endotoxin to deacylation by acyloxyacyl hydrolase. J Biol Chem, 2007, 282: 7877-7884.","journal-title":"J Biol Chem"},{"key":"CITATION76","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1084\/jem.176.2.485","volume":"176","author":"Kitchens RL","year":"1992","unstructured":"Kitchens RL, Ulevitch RJ, Munford RS. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med, 1992, 176: 485-494.","journal-title":"J Exp Med"},{"key":"CITATION77","doi-asserted-by":"publisher","first-page":"9904","DOI":"10.1074\/jbc.270.17.9904","volume":"270","author":"Kitchens RL","year":"1995","unstructured":"Kitchens RL, Munford RS. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biol Chem, 1995, 270: 9904-9910.","journal-title":"J Biol Chem"},{"key":"CITATION78","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ni1246","volume":"6","author":"Lu M","year":"2005","unstructured":"Lu M, Zhang M, Takashima A, Weiss J, Apicella MA, Li XH, Yuan D. Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to gram-negative bacteria. Nat Immunol, 2005, 6: 989-994.","journal-title":"Nat Immunol"},{"key":"CITATION79","doi-asserted-by":"publisher","first-page":"e1006436","DOI":"10.1371\/journal.ppat.1006436","volume":"13","author":"Zou B","year":"2017","unstructured":"Zou B, Jiang W, Han H, Li J, Mao W, Tang Z, Yang Q. Acyloxyacyl hydrolase promotes the resolution of lipopolysaccharide-induced acute lung injury. PLoS Pathog, 2017, 13:","journal-title":"PLoS Pathog"},{"key":"CITATION80","doi-asserted-by":"publisher","first-page":"103004","DOI":"10.1016\/j.isci.2021.103004","volume":"24","author":"Feng J","year":"2021","unstructured":"Feng J, Jiang W, Cheng X, Zou B, Varley AW, Liu T, Qian G. A host lipase prevents lipopolysaccharide-induced foam cell formation. iScience, 2021, 24:","journal-title":"iScience"},{"key":"CITATION81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.chom.2008.06.009","volume":"4","author":"Lu M","year":"2008","unstructured":"Lu M, Varley AW, Ohta S, Hardwick J, Munford RS. Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection. Cell Host Microbe, 2008, 4: 293-302.","journal-title":"Cell Host Microbe"},{"key":"CITATION82","doi-asserted-by":"publisher","first-page":"e1003339","DOI":"10.1371\/journal.ppat.1003339","volume":"9","author":"Lu M","year":"2013","unstructured":"Lu M, Varley AW, Munford RS, Zamboni DS.  Persistently active microbial molecules prolong innate immune tolerance in vivo . PLoS Pathog, 2013, 9:","journal-title":"PLoS Pathog"},{"key":"CITATION83","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1084\/jem.20172225","volume":"215","author":"Qian G","year":"2018","unstructured":"Qian G, Jiang W, Zou B, Feng J, Cheng X, Gu J, Chu T. LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma. J Exp Med, 2018, 215: 2397-2412.","journal-title":"J Exp Med"},{"key":"CITATION84","doi-asserted-by":"publisher","first-page":"e1011556","DOI":"10.1371\/journal.ppat.1011556","volume":"19","author":"Cheng X","year":"2023","unstructured":"Cheng X, Jiang W, Chen Y, Zou B, Wang Z, Gan L, Xiao Z. Acyloxyacyl hydrolase promotes pulmonary defense by preventing alveolar macrophage tolerance. PLoS Pathog, 2023, 19:","journal-title":"PLoS Pathog"},{"key":"CITATION85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.trsl.2024.03.007","volume":"270","author":"Zhu Y","year":"2024","unstructured":"Zhu Y, Hu Y, Liu Z, Chang L, Geng X, Yin X, Zhao BQ. The LPS-inactivating enzyme acyloxyacyl hydrolase protects the brain from experimental stroke. Transl Res, 2024, 270: 42-51.","journal-title":"Transl Res"},{"key":"CITATION86","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.7150\/ijbs.91237","volume":"20","author":"Wu Z","year":"2024","unstructured":"Wu Z, Deng B, Shen Y, Li X, Li J, Li Y, Ma S. Acyloxyacyl hydrolase protects against kidney injury via inhibition of tubular CD74-macrophage crosstalk. Int J Biol Sci, 2024, 20: 3061-3075.","journal-title":"Int J Biol Sci"},{"key":"CITATION87","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00109-022-02252-w","volume":"100","author":"Cheng X","year":"2022","unstructured":"Cheng X, Song X, Li Z, Yuan C, Lei X, Feng M, Hong Z. Acyloxyacyl hydrolase deficiency induces chronic inflammation and bone loss in male mice. J Mol Med, 2022, 100: 1599-1616.","journal-title":"J Mol Med"},{"key":"CITATION88","doi-asserted-by":"publisher","first-page":"10116","DOI":"10.1016\/S0021-9258(19)50207-1","volume":"267","author":"Munford RS","year":"1992","unstructured":"Munford RS, Hunter JP.  Acyloxyacyl hydrolase, a leukocyte enzyme that deacylates bacterial lipopolysaccharides, has phospholipase, lysophospholipase, diacylglycerollipase, and acyltransferase activities in vitro . J Biol Chem, 1992, 267: 10116-10121.","journal-title":"J Biol Chem"},{"key":"CITATION89","doi-asserted-by":"publisher","first-page":"e70938","DOI":"10.7554\/eLife.70938","volume":"10","author":"Zou B","year":"2021","unstructured":"Zou B, Goodwin M, Saleem D, Jiang W, Tang J, Chu Y, Munford RS. A highly conserved host lipase deacylates oxidized phospholipids and ameliorates acute lung injury in mice. eLife, 2021, 10:","journal-title":"eLife"},{"key":"CITATION90","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1016\/j.cell.2025.07.004","volume":"188","author":"Gong L","year":"2025","unstructured":"Gong L, Luo J, Yang E, Ru B, Qi Z, Yang Y, Rani A. Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy. Cell, 2025, 188: 5062-5080.e32.","journal-title":"Cell"},{"key":"CITATION91","doi-asserted-by":"publisher","first-page":"15650","DOI":"10.3748\/wjg.v20.i42.15650","volume":"20","author":"Estaki M","year":"2014","unstructured":"Estaki M. Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity. World J Gastroenterol, 2014, 20: 15650-15656.","journal-title":"World J Gastroenterol"},{"key":"CITATION92","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nri1004","volume":"3","author":"Beutler B","year":"2003","unstructured":"Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol, 2003, 3: 169-176.","journal-title":"Nat Rev Immunol"},{"key":"CITATION93","unstructured":"Poelstra K, Bakker WW, Klok PA, Hardonk MJ, Meijer DK. A physiologic function for alkaline phosphatase: endotoxin detoxification.  Lab Invest  1997, 76: 319\u2013327 ."},{"key":"CITATION94","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0009-9120(02)00330-2","volume":"35","author":"Koyama I","year":"2002","unstructured":"Koyama I, Matsunaga T, Harada T, Hokari S, Komoda T.  Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation . Clin Biochem, 2002, 35: 455-461.","journal-title":"Clin Biochem"},{"key":"CITATION95","doi-asserted-by":"publisher","first-page":"eaao5610","DOI":"10.1126\/science.aao5610","volume":"358","author":"Yang WH","year":"2017","unstructured":"Yang WH, Heithoff DM, Aziz PV, Sperandio M, Nizet V, Mahan MJ, Marth JD. Recurrent infection progressively disables host protection against intestinal inflammation. Science, 2017, 358:","journal-title":"Science"},{"key":"CITATION96","doi-asserted-by":"publisher","first-page":"bvz039","DOI":"10.1210\/jendso\/bvz039","volume":"4","author":"Ghosh SS","year":"2020","unstructured":"Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocrine Soc, 2020, 4:","journal-title":"J Endocrine Soc"},{"key":"CITATION97","doi-asserted-by":"publisher","first-page":"G467","DOI":"10.1152\/ajpgi.00364.2009","volume":"299","author":"Chen KT","year":"2010","unstructured":"Chen KT, Malo MS, Moss AK, Zeller S, Johnson P, Ebrahimi F, Mostafa G. Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase. Am J Physiol Gastrointestinal Liver Physiol, 2010, 299: G467-G475.","journal-title":"Am J Physiol Gastrointestinal Liver Physiol"},{"key":"CITATION98","doi-asserted-by":"publisher","first-page":"G597","DOI":"10.1152\/ajpgi.00455.2012","volume":"304","author":"Moss AK","year":"2013","unstructured":"Moss AK, Hamarneh SR, Mohamed MMR, Ramasamy S, Yammine H, Patel P, Kaliannan K. Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate. Am J Physiol Gastrointestinal Liver Physiol, 2013, 304: G597-G604.","journal-title":"Am J Physiol Gastrointestinal Liver Physiol"},{"key":"CITATION99","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1126\/science.1100747","volume":"306","author":"Zimmermann R","year":"2004","unstructured":"Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science, 2004, 306: 1383-1386.","journal-title":"Science"},{"key":"CITATION100","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41589-024-01569-6","volume":"20","author":"Li W","year":"2024","unstructured":"Li W, Liu Q, Qian Y, Wang C, Kong C, Sun L, Sun L. Adipose triglyceride lipase suppresses noncanonical inflammasome by hydrolyzing LPS. Nat Chem Biol, 2024, 20: 1434-1442.","journal-title":"Nat Chem Biol"},{"key":"CITATION101","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"Camilleri M","year":"2019","unstructured":"Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut, 2019, 68: 1516-1526.","journal-title":"Gut"},{"key":"CITATION102","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"Turner JR","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol, 2009, 9: 799-809.","journal-title":"Nat Rev Immunol"},{"key":"CITATION103","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrgastro.2013.35","volume":"10","author":"Johansson MEV","year":"2013","unstructured":"Johansson MEV, Sj\u00f6vall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol, 2013, 10: 352-361.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"CITATION104","doi-asserted-by":"publisher","first-page":"594150","DOI":"10.3389\/fimmu.2020.594150","volume":"11","author":"Mohammad S","year":"2020","unstructured":"Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol, 2020, 11:","journal-title":"Front Immunol"},{"key":"CITATION105","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.immuni.2014.12.028","volume":"42","author":"Mukherjee S","year":"2015","unstructured":"Mukherjee S, Hooper LV. Antimicrobial defense of the intestine. Immunity, 2015, 42: 28-39.","journal-title":"Immunity"},{"key":"CITATION106","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jcmgh.2021.02.007","volume":"11","author":"Ghosh S","year":"2021","unstructured":"Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of intestinal barrier function by microbial metabolites. Cell Mol Gastroenterol Hepatol, 2021, 11: 1463-1482.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"CITATION107","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/08830185.2015.1087518","volume":"35","author":"Gnauck A","year":"2016","unstructured":"Gnauck A, Lentle RG, Kruger MC. The characteristics and function of bacterial lipopolysaccharides and their endotoxic potential in humans. Int Rev Immunol, 2016, 35: 189-218.","journal-title":"Int Rev Immunol"},{"key":"CITATION108","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41579-023-00969-0","volume":"22","author":"McCallum G","year":"2024","unstructured":"McCallum G, Tropini C. The gut microbiota and its biogeography. Nat Rev Microbiol, 2024, 22: 105-118.","journal-title":"Nat Rev Microbiol"},{"key":"CITATION109","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/0966-842x(96)10057-3","volume":"4","author":"Berg R","year":"1996","unstructured":"Berg R. The indigenous gastrointestinal microflora. Trends Microbiol, 1996, 4: 430-435.","journal-title":"Trends Microbiol"},{"key":"CITATION110","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1017\/S0007114510003004","volume":"105","author":"Erridge C","year":"2011","unstructured":"Erridge C.  The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4 . Br J Nutr, 2011, 105: 15-23.","journal-title":"Br J Nutr"},{"key":"CITATION111","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1194\/jlr.M800156-JLR200","volume":"50","author":"Ghoshal S","year":"2009","unstructured":"Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res, 2009, 50: 90-97.","journal-title":"J Lipid Res"},{"key":"CITATION112","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1152\/ajpgi.00098.2016","volume":"311","author":"Guerville M","year":"2016","unstructured":"Guerville M, Boudry G. Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation. Am J Physiol Gastrointestinal Liver Physiol, 2016, 311: G1-G15.","journal-title":"Am J Physiol Gastrointestinal Liver Physiol"},{"key":"CITATION113","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1172\/JCI119427","volume":"99","author":"Rensen PC","year":"1997","unstructured":"Rensen PC, Oosten M, Bilt E, Eck M, Kuiper J, Berkel TJ.  Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo . J Clin Invest, 1997, 99: 2438-2445.","journal-title":"J Clin Invest"},{"key":"CITATION114","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1172\/JCI116259","volume":"91","author":"Harris HW","year":"1993","unstructured":"Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones AL, Eichbaum EB. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest, 1993, 91: 1028-1034.","journal-title":"J Clin Invest"},{"key":"CITATION115","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jnutbio.2009.11.011","volume":"22","author":"Laugerette F","year":"2011","unstructured":"Laugerette F, Vors C, G\u00e9lo\u00ebn A, Chauvin MA, Soulage C, Lambert-Porcheron S, Peretti N. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutral Biochem, 2011, 22: 53-59.","journal-title":"J Nutral Biochem"},{"key":"CITATION116","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/ajcn\/87.5.1219","volume":"87","author":"Amar J","year":"2008","unstructured":"Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr, 2008, 87: 1219-1223.","journal-title":"Am J Clin Nutr"},{"key":"CITATION117","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","volume":"57","author":"Cani PD","year":"2008","unstructured":"Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes, 2008, 57: 1470-1481.","journal-title":"Diabetes"},{"key":"CITATION118","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/gut.2008.165886","volume":"58","author":"Cani PD","year":"2009","unstructured":"Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut, 2009, 58: 1091-1103.","journal-title":"Gut"},{"key":"CITATION119","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1023\/B:DDAS.0000026302.92898.ae","volume":"49","author":"Griffiths EA","year":"2004","unstructured":"Griffiths EA, Duffy LC, Schanbacher FL, Qiao H, Dryja D, Leavens A, Rossman J.  In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb\/c mice . Dig Dis Sci, 2004, 49: 579-589.","journal-title":"Dig Dis Sci"},{"key":"CITATION120","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/oby.21122","volume":"23","author":"Lam YY","year":"2015","unstructured":"Lam YY, Ha CWY, Hoffmann JMA, Oscarsson J, Dinudom A, Mather TJ, Cook DI. Effects of dietary fat profile on gut permeability and microbiota and their relationships with metabolic changes in mice. Obesity, 2015, 23: 1429-1439.","journal-title":"Obesity"},{"key":"CITATION121","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1017\/S0007114514000117","volume":"111","author":"Patterson E","year":"2014","unstructured":"Patterson E, O\u2032Doherty RM, Murphy EF, Wall R, O\u2032Sullivan O, Nilaweera K, Fitzgerald GF. Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL\/6J mice. Br J Nutr, 2014, 111: 1905-1917.","journal-title":"Br J Nutr"},{"key":"CITATION122","doi-asserted-by":"publisher","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","volume":"292","author":"Brun P","year":"2007","unstructured":"Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Pal\u00f9 G, Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointestinal Liver Physiol, 2007, 292: G518-G525.","journal-title":"Am J Physiol Gastrointestinal Liver Physiol"},{"key":"CITATION123","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1743-7075-7-19","volume":"7","author":"Suzuki T","year":"2010","unstructured":"Suzuki T, Hara H. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond), 2010, 7:","journal-title":"Nutr Metab (Lond)"},{"key":"CITATION124","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1017\/S0007114512001213","volume":"108","author":"Moreira APB","year":"2012","unstructured":"Moreira APB, Texeira TFS, Ferreira AB, do Carmo Gouveia Peluzio M, de C\u00e1ssia Gon\u00e7alves Alfenas R. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr, 2012, 108: 801-809.","journal-title":"Br J Nutr"},{"key":"CITATION125","doi-asserted-by":"publisher","first-page":"eabe6729","DOI":"10.1126\/science.abe6729","volume":"373","author":"Han YH","year":"2021","unstructured":"Han YH, Onufer EJ, Huang LH, Sprung RW, Davidson WS, Czepielewski RS, Wohltmann M. Enterically derived high-density lipoprotein restrains liver injury through the portal vein. Science, 2021, 373:","journal-title":"Science"},{"key":"CITATION126","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Fan Y","year":"2021","unstructured":"Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol, 2021, 19: 55-71.","journal-title":"Nat Rev Microbiol"},{"key":"CITATION127","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.3390\/ijms22147613","volume":"22","author":"Usuda H","year":"2021","unstructured":"Usuda H, Okamoto T, Wada K. Leaky gut: effect of dietary fiber and fats on microbiome and intestinal barrier. Int J Mol Sci, 2021, 22:","journal-title":"Int J Mol Sci"},{"key":"CITATION128","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.mayocp.2023.05.026","volume":"98","author":"Busebee B","year":"2023","unstructured":"Busebee B, Ghusn W, Cifuentes L, Acosta A. Obesity: a review of pathophysiology and classification. Mayo Clinic Proc, 2023, 98: 1842-1857.","journal-title":"Mayo Clinic Proc"},{"key":"CITATION129","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.2337\/dc13-0451","volume":"36","author":"Tr\u00f8seid M","year":"2013","unstructured":"Tr\u00f8seid M, Nestvold TK, Rudi K, Thoresen H, Nielsen EW, Lappeg\u00e5rd KT. Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity. Diabetes Care, 2013, 36: 3627-3632.","journal-title":"Diabetes Care"},{"key":"CITATION130","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.biochi.2015.06.020","volume":"124","author":"Boutagy NE","year":"2016","unstructured":"Boutagy NE, McMillan RP, Frisard MI, Hulver MW. Metabolic endotoxemia with obesity: is it real and is it relevant?. Biochimie, 2016, 124: 11-20.","journal-title":"Biochimie"},{"key":"CITATION131","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.cmet.2015.07.026","volume":"22","author":"Caesar R","year":"2015","unstructured":"Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani PD, B\u00e4ckhed F. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab, 2015, 22: 658-668.","journal-title":"Cell Metab"},{"key":"CITATION132","doi-asserted-by":"publisher","first-page":"e47713","DOI":"10.1371\/journal.pone.0047713","volume":"7","author":"Kim KA","year":"2012","unstructured":"Kim KA, Gu W, Lee IA, Joh EH, Kim DH, Chamaillard M. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One, 2012, 7:","journal-title":"PLoS One"},{"key":"CITATION133","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1073\/pnas.1220180110","volume":"110","author":"Kaliannan K","year":"2013","unstructured":"Kaliannan K, Hamarneh SR, Economopoulos KP, Nasrin Alam S, Moaven O, Patel P, Malo NS. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci USA, 2013, 110: 7003-7008.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION134","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","volume":"65","author":"Dao MC","year":"2016","unstructured":"Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, Kayser BD.  Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology . Gut, 2016, 65: 426-436.","journal-title":"Gut"},{"key":"CITATION135","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.115.019645","volume":"133","author":"Li J","year":"2016","unstructured":"Li J, Lin S, Vanhoutte PM, Woo CW, Xu A.  Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in apoe\u2013\/\u2013 mice . Circulation, 2016, 133: 2434-2446.","journal-title":"Circulation"},{"key":"CITATION136","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/obr.12370","volume":"17","author":"Hersoug L","year":"2016","unstructured":"Hersoug L, M\u00f8ller P, Loft S. Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity. Obesity Rev, 2016, 17: 297-312.","journal-title":"Obesity Rev"},{"key":"CITATION137","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ajpath.2012.10.014","volume":"182","author":"Guo S","year":"2013","unstructured":"Guo S, Al-Sadi R, Said HM, Ma TY.  Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14 . Am J Pathol, 2013, 182: 375-387.","journal-title":"Am J Pathol"},{"key":"CITATION138","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12916-023-02857-z","volume":"21","author":"Omran F","year":"2023","unstructured":"Omran F, Murphy AM, Younis AZ, Kyrou I, Vrbikova J, Hainer V, Sramkova P. The impact of metabolic endotoxaemia on the browning process in human adipocytes. BMC Med, 2023, 21:","journal-title":"BMC Med"},{"key":"CITATION139","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1042\/BJ20100285","volume":"430","author":"Barbarroja N","year":"2010","unstructured":"Barbarroja N, L\u00f3pez-Pedrera R, Mayas MD, Garc\u00eda-Fuentes E, Garrido-S\u00e1nchez L, Mac\u00edas-Gonz\u00e1lez M, El Bekay R. The obese healthy paradox: is inflammation the answer?. Biochem J, 2010, 430: 141-149.","journal-title":"Biochem J"},{"key":"CITATION140","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","volume":"1801","author":"Virtue S","year":"2010","unstructured":"Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome\u2014an allostatic perspective. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids, 2010, 1801: 338-349.","journal-title":"Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids"},{"key":"CITATION141","doi-asserted-by":"publisher","first-page":"e37420","DOI":"10.7554\/eLife.37420","volume":"7","author":"Jensen AB","year":"2018","unstructured":"Jensen AB, S\u00f8rensen TI, Pedersen O, Jess T, Brunak S, Allin KH. Increase in clinically recorded type 2 diabetes after colectomy. eLife, 2018, 7:","journal-title":"eLife"},{"key":"CITATION142","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2337\/dc10-1676","volume":"34","author":"Pussinen PJ","year":"2011","unstructured":"Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care, 2011, 34: 392-397.","journal-title":"Diabetes Care"},{"key":"CITATION143","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.2337\/dc10-2197","volume":"34","author":"Lassenius MI","year":"2011","unstructured":"Lassenius MI, Pietil\u00e4inen KH, Kaartinen K, Pussinen PJ, Syrj\u00e4nen J, Forsblom C, P\u00f6rsti I. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care, 2011, 34: 1809-1815.","journal-title":"Diabetes Care"},{"key":"CITATION144","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1475-2840-8-20","volume":"8","author":"Al-Attas OS","year":"2009","unstructured":"Al-Attas OS, Al-Daghri NM, Al-Rubeaan K, da Silva NF, Sabico SL, Kumar S, McTernan PG. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol, 2009, 8:","journal-title":"Cardiovasc Diabetol"},{"key":"CITATION145","doi-asserted-by":"publisher","first-page":"E740","DOI":"10.1152\/ajpendo.00302.2006","volume":"292","author":"Creely SJ","year":"2007","unstructured":"Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, Evans M. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol-Endocrinol Metab, 2007, 292: E740-E747.","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"CITATION146","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db09-0367","volume":"59","author":"Mehta NN","year":"2010","unstructured":"Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, Tabita-Martinez J. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes, 2010, 59: 172-181.","journal-title":"Diabetes"},{"key":"CITATION147","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.2337\/db09-0256","volume":"58","author":"Shah R","year":"2009","unstructured":"Shah R, Lu Y, Hinkle CC, McGillicuddy FC, Kim R, Hannenhalli S, Cappola TP.  Gene profiling of human adipose tissue during evoked inflammation in vivo . Diabetes, 2009, 58: 2211-2219.","journal-title":"Diabetes"},{"key":"CITATION148","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/metabo15060397","volume":"15","author":"Yu Y","year":"2025","unstructured":"Yu Y, Ding Y, Wang S, Jiang L. Gut microbiota dysbiosis and its impact on type 2 diabetes: from pathogenesis to therapeutic strategies. Metabolites, 2025, 15:","journal-title":"Metabolites"},{"key":"CITATION149","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/gutjnl-2011-301012","volume":"61","author":"Serino M","year":"2012","unstructured":"Serino M, Luche E, Gres S, Baylac A, Berg\u00e9 M, Cenac C, Waget A. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut, 2012, 61: 543-553.","journal-title":"Gut"},{"key":"CITATION150","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1007\/s00125-011-2329-8","volume":"54","author":"Amar J","year":"2011","unstructured":"Amar J, Serino M, Lange C, Chabo C, Iacovoni J, Mondot S, Lepage P. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia, 2011, 54: 3055-3061.","journal-title":"Diabetologia"},{"key":"CITATION151","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"Shin NR","year":"2014","unstructured":"Shin NR, Lee JC, Lee HY, Kim MS, Whon TW, Lee MS, Bae JW.  An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice . Gut, 2014, 63: 727-735.","journal-title":"Gut"},{"key":"CITATION152","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41366-024-01581-9","volume":"48","author":"Rafiei H","year":"2024","unstructured":"Rafiei H, Yeung M, Kowalski S, Li MY, Harris D, Chang J, Nguyen N. Butyrate and tributyrin reduce LPS-induced inflammatory cytokine production from human visceral fat. Int J Obes, 2024, 48: 1559-1567.","journal-title":"Int J Obes"},{"key":"CITATION153","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1530\/JME-19-0132","volume":"64","author":"Noureldein MH","year":"2020","unstructured":"Noureldein MH, Bitar S, Youssef N, Azar S, Eid AA. Butyrate modulates diabetes-linked gut dysbiosis: epigenetic and mechanistic modifications. J Mol Endocrinol, 2020, 64: 29-42.","journal-title":"J Mol Endocrinol"},{"key":"CITATION154","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","volume":"63","author":"Tilg H","year":"2014","unstructured":"Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut, 2014, 63: 1513-1521.","journal-title":"Gut"},{"key":"CITATION155","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.3390\/ijms18102034","volume":"18","author":"Wu MY","year":"2017","unstructured":"Wu MY, Li CJ, Hou MF, Chu PY. New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci, 2017, 18:","journal-title":"Int J Mol Sci"},{"key":"CITATION156","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"Libby P","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature, 2021, 592: 524-533.","journal-title":"Nature"},{"key":"CITATION157","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0735-1097(99)00448-9","volume":"34","author":"Wiedermann CJ","year":"1999","unstructured":"Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F, Willeit J. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease. J Am Coll Cardiol, 1999, 34: 1975-1981.","journal-title":"J Am Coll Cardiol"},{"key":"CITATION158","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1161\/ATVBAHA.106.138743","volume":"27","author":"Pussinen PJ","year":"2007","unstructured":"Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol, 2007, 27: 1433-1439.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CITATION159","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2215\/CJN.03600807","volume":"3","author":"Szeto CC","year":"2008","unstructured":"Szeto CC, Kwan BCH, Chow KM, Lai KB, Chung KY, Leung CB, Li PKT. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol, 2008, 3: 431-436.","journal-title":"Clin J Am Soc Nephrol"},{"key":"CITATION160","doi-asserted-by":"publisher","first-page":"119220","DOI":"10.1016\/j.atherosclerosis.2025.119220","volume":"405","author":"Parantainen J","year":"2025","unstructured":"Parantainen J, Barreto G, Strandberg TE, Mars N, Nurmi K, Eklund KK. Increased intestinal mucosal permeability and metabolic endotoxemia predict the risk of cardiovascular mortality. Atherosclerosis, 2025, 405:","journal-title":"Atherosclerosis"},{"key":"CITATION161","doi-asserted-by":"publisher","first-page":"10679","DOI":"10.1073\/pnas.0403249101","volume":"101","author":"Michelsen KS","year":"2004","unstructured":"Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA, 2004, 101: 10679-10684.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION162","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nm1008","volume":"10","author":"Bj\u00f6rkbacka H","year":"2004","unstructured":"Bj\u00f6rkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med, 2004, 10: 416-421.","journal-title":"Nat Med"},{"key":"CITATION163","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1161\/ATVBAHA.112.249847","volume":"32","author":"Ding Y","year":"2012","unstructured":"Ding Y, Subramanian S, Montes VN, Goodspeed L, Wang S, Han CY, Teresa Iii AS. Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol, 2012, 32: 1596-1604.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CITATION164","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.120.317144","volume":"128","author":"Ghosh SS","year":"2021","unstructured":"Ghosh SS, Wang J, Yannie PJ, Cooper RC, Sandhu YK, Kakiyama G, Korzun WJ. Over-expression of intestinal alkaline phosphatase attenuates atherosclerosis. Circ Res, 2021, 128: 1646-1659.","journal-title":"Circ Res"},{"key":"CITATION165","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","volume":"20","author":"Violi F","year":"2023","unstructured":"Violi F, Cammisotto V, Bartimoccia S, Pignatelli P, Carnevale R, Nocella C. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat Rev Cardiol, 2023, 20: 24-37.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION166","doi-asserted-by":"publisher","first-page":"S340","DOI":"10.1194\/jlr.R800056-JLR200","volume":"50","author":"Curtiss LK","year":"2009","unstructured":"Curtiss LK, Tobias PS. Emerging role of toll-like receptors in atherosclerosis. J Lipid Res, 2009, 50: S340-S345.","journal-title":"J Lipid Res"},{"key":"CITATION167","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.120.046677","volume":"143","author":"Schumski A","year":"2021","unstructured":"Schumski A, Ortega-G\u00f3mez A, Wichapong K, Winter C, Lemnitzer P, Viola JR, Pinilla-Vera M. Endotoxinemia accelerates atherosclerosis through electrostatic charge-mediated monocyte adhesion. Circulation, 2021, 143: 254-266.","journal-title":"Circulation"},{"key":"CITATION168","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1161\/01.ATV.20.6.1536","volume":"20","author":"Memon RA","year":"2000","unstructured":"Memon RA, Staprans I, Noor M, Holleran WM, Uchida Y, Moser AH, Feingold KR.  Infection and inflammation induce ldl oxidation in vivo . Arterioscler Thromb Vasc Biol, 2000, 20: 1536-1542.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CITATION169","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/cvr\/cvy130","volume":"114","author":"Mawhin MA","year":"2018","unstructured":"Mawhin MA, Tilly P, Zirka G, Charles AL, Slimani F, Vonesch JL, Michel JB. Neutrophils recruited by leukotriene B4 induce features of plaque destabilization during endotoxaemia. Cardiovasc Res, 2018, 114: 1656-1666.","journal-title":"Cardiovasc Res"},{"key":"CITATION170","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"Friedman SL","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med, 2018, 24: 908-922.","journal-title":"Nat Med"},{"key":"CITATION171","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"Wong VWS","year":"2023","unstructured":"Wong VWS, Ekstedt M, Wong GLH, Hagstr\u00f6m H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol, 2023, 79: 842-852.","journal-title":"J Hepatol"},{"key":"CITATION172","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.cgh.2022.07.033","volume":"21","author":"Le P","year":"2023","unstructured":"Le P, Payne JY, Zhang L, Deshpande A, Rothberg MB, Alkhouri N, Herman W. Disease state transition probabilities across the spectrum of NAFLD: a systematic review and meta-analysis of paired biopsy or imaging studies. Clin Gastroenterol Hepatol, 2023, 21: 1154-1168.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"CITATION173","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"Albillos A","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol, 2020, 72: 558-577.","journal-title":"J Hepatol"},{"key":"CITATION174","doi-asserted-by":"crossref","unstructured":"Munford RS. Endotoxin(s) and the liver.  Gastroenterology  1978, 75: 532\u2013535 .","DOI":"10.1016\/0016-5085(78)90867-3"},{"key":"CITATION175","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/nu12030699","volume":"12","author":"Nier A","year":"2020","unstructured":"Nier A, Huber Y, Labenz C, Michel M, Bergheim I, Schattenberg J. Adipokines and endotoxemia correlate with hepatic steatosis in non-alcoholic fatty liver disease (NAFLD). Nutrients, 2020, 12:","journal-title":"Nutrients"},{"key":"CITATION176","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/jn\/138.8.1452","volume":"138","author":"Thuy S","year":"2008","unstructured":"Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, K\u00f6nigsrainer A, Maier KP. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr, 2008, 138: 1452-1455.","journal-title":"J Nutr"},{"key":"CITATION177","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-9255-7-15","volume":"7","author":"Harte AL","year":"2010","unstructured":"Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, Tripathi G. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm, 2010, 7:","journal-title":"J Inflamm"},{"key":"CITATION178","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/apt.14119","volume":"46","author":"Pang J","year":"2017","unstructured":"Pang J, Xu W, Zhang X, Wong GL, Chan AW, Chan HY, Tse CH. Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther, 2017, 46: 175-182.","journal-title":"Aliment Pharmacol Ther"},{"key":"CITATION179","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","volume":"26","author":"An L","year":"2022","unstructured":"An L, Wirth U, Koch D, Schirren M, Drefs M, Koliogiannis D, Nie\u03b2 H. The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases. J Gastrointestinal Surg, 2022, 26: 671-683.","journal-title":"J Gastrointestinal Surg"},{"key":"CITATION180","doi-asserted-by":"publisher","first-page":"e70932","DOI":"10.1096\/fj.202403293RR","volume":"39","author":"Xin Z","year":"2025","unstructured":"Xin Z, Wang Z, Chu M. Insights into intestinal flora in metabolic dysfunction-associated steatotic liver disease. FASEB J, 2025, 39:","journal-title":"FASEB J"},{"key":"CITATION181","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nutres.2021.04.008","volume":"91","author":"Vasques-Monteiro IML","year":"2021","unstructured":"Vasques-Monteiro IML, Silva-Veiga FM, Miranda CS, de Andrade Gon\u00e7alves \u00c9CB, Daleprane JB, Souza-Mello V.  A rise in Proteobacteria is an indicator of gut-liver axis-mediated nonalcoholic fatty liver disease in high-fructose-fed adult mice . Nutr Res, 2021, 91: 26-35.","journal-title":"Nutr Res"},{"key":"CITATION182","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"Zhu L","year":"2013","unstructured":"Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology, 2013, 57: 601-609.","journal-title":"Hepatology"},{"key":"CITATION183","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","volume":"1","author":"Lefere S","year":"2019","unstructured":"Lefere S, Tacke F. Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism. JHEP Rep, 2019, 1: 30-43.","journal-title":"JHEP Rep"},{"key":"CITATION184","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2337\/db09-1403","volume":"59","author":"Obstfeld AE","year":"2010","unstructured":"Obstfeld AE, Sugaru E, Thearle M, Francisco AM, Gayet C, Ginsberg HN, Ables EV. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes, 2010, 59: 916-925.","journal-title":"Diabetes"},{"key":"CITATION185","doi-asserted-by":"crossref","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, Cummings J, et al. Alzheimer\u2019s disease.  Lancet  2021, 397: 1577\u20131590 .","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"CITATION186","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrn2967","volume":"12","author":"Ittner LM","year":"2011","unstructured":"Ittner LM, G\u00f6tz J. Amyloid-\u03b2 and tau\u2014a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci, 2011, 12: 67-72.","journal-title":"Nat Rev Neurosci"},{"key":"CITATION187","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-024-00722-y","volume":"19","author":"Brown GC","year":"2024","unstructured":"Brown GC, Heneka MT. The endotoxin hypothesis of Alzheimer\u2019s disease. Mol neurodegeneration, 2024, 19:","journal-title":"Mol neurodegeneration"},{"key":"CITATION188","doi-asserted-by":"publisher","first-page":"110576","DOI":"10.1016\/j.nut.2019.110576","volume":"69","author":"Saiyasit N","year":"2020","unstructured":"Saiyasit N, Chunchai T, Prus D, Suparan K, Pittayapong P, Apaijai N, Pratchayasakul W. Gut dysbiosis develops before metabolic disturbance and cognitive decline in high-fat diet\u2013induced obese condition. Nutrition, 2020, 69:","journal-title":"Nutrition"},{"key":"CITATION189","doi-asserted-by":"publisher","first-page":"107905","DOI":"10.1016\/j.micpath.2025.107905","volume":"207","author":"Mehboodi M","year":"2025","unstructured":"Mehboodi M, Namdari MPMA, Abdollahi Z, Mobarezi Z, Kiani M, Chamani F, Khanbabaie H. The relationship between increased levels of microbiota-derived lipopolysaccharide in obesity and the pathophysiology of neurodegenerative diseases. Microb Pathog, 2025, 207:","journal-title":"Microb Pathog"},{"key":"CITATION190","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","volume":"6","author":"Martin CR","year":"2018","unstructured":"Martin CR, Osadchiy V, Kalani A, Mayer EA. The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol, 2018, 6: 133-148.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"CITATION191","doi-asserted-by":"publisher","first-page":"577561","DOI":"10.1016\/j.jneuroim.2021.577561","volume":"357","author":"Andreadou EG","year":"2021","unstructured":"Andreadou EG, Katsipis G, Tsolaki M, Pantazaki AA. Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer\u2019s disease and mild cognitive impairment patients. J Neuroimmunol, 2021, 357:","journal-title":"J Neuroimmunol"},{"key":"CITATION192","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3390\/nu15040932","volume":"15","author":"S\u00e1nchez-Tapia M","year":"2023","unstructured":"S\u00e1nchez-Tapia M, Mimenza-Alvarado A, Granados-Dom\u00ednguez L, Flores-L\u00f3pez A, L\u00f3pez-Barradas A, Ortiz V, P\u00e9rez-Cruz C. The gut microbiota\u2013brain axis during aging, mild cognitive impairment and dementia: role of tau protein, \u03b2-amyloid and LPS in serum and curli protein in stool. Nutrients, 2023, 15:","journal-title":"Nutrients"},{"key":"CITATION193","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnagi.2018.00042","volume":"10","author":"Zhan X","year":"2018","unstructured":"Zhan X, Stamova B, Sharp FR. Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in Alzheimer\u2019s disease brain: a review. Front Aging Neurosci, 2018, 10:","journal-title":"Front Aging Neurosci"},{"key":"CITATION194","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jneuroim.2008.09.017","volume":"206","author":"Zhang R","year":"2009","unstructured":"Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M, Narvaez A. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol, 2009, 206: 121-124.","journal-title":"J Neuroimmunol"},{"key":"CITATION195","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fcimb.2017.00318","volume":"7","author":"Zhao Y","year":"2017","unstructured":"Zhao Y, Jaber V, Lukiw WJ. Secretory products of the human GI tract microbiome and their potential impact on Alzheimer\u2019s disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus. Front Cell Infect Microbiol, 2017, 7:","journal-title":"Front Cell Infect Microbiol"},{"key":"CITATION196","doi-asserted-by":"publisher","first-page":"15369","DOI":"10.1523\/JNEUROSCI.2637-10.2010","volume":"30","author":"Reed-Geaghan EG","year":"2010","unstructured":"Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE. Deletion of CD14 attenuates Alzheimer\u2019s disease pathology by influencing the brain\u2019s inflammatory milieu. J Neurosci, 2010, 30: 15369-15373.","journal-title":"J Neurosci"},{"key":"CITATION197","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/molecules31030486","volume":"31","author":"Zhao Y","year":"2026","unstructured":"Zhao Y, Sharfman NM, Jaber VR, Taylor CM, Lukiw WJ, Bazan NG. Down-regulation of acyloxyacyl hydrolase expression in Alzheimer\u2019s disease impairs LPS detoxification and contributes to brain pro-inflammatory signaling. Molecules, 2026, 31:","journal-title":"Molecules"},{"key":"CITATION198","doi-asserted-by":"publisher","first-page":"768108","DOI":"10.3389\/fcimb.2021.768108","volume":"11","author":"Peng X","year":"2021","unstructured":"Peng X, Luo Z, He S, Zhang L, Li Y. Blood-brain barrier disruption by lipopolysaccharide and sepsis-associated encephalopathy. Front Cell Infect Microbiol, 2021, 11:","journal-title":"Front Cell Infect Microbiol"},{"key":"CITATION199","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbi.2009.09.001","volume":"24","author":"Banks WA","year":"2010","unstructured":"Banks WA, Robinson SM. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav Immun, 2010, 24: 102-109.","journal-title":"Brain Behav Immun"},{"key":"CITATION200","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bbi.2004.01.004","volume":"18","author":"Perry VH","year":"2004","unstructured":"Perry VH. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun, 2004, 18: 407-413.","journal-title":"Brain Behav Immun"},{"key":"CITATION201","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.brainresrev.2004.12.015","volume":"48","author":"Minghetti L","year":"2005","unstructured":"Minghetti L, Ajmone-Cat MA, De Berardinis MA, De Simone R. Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation. Brain Res Rev, 2005, 48: 251-256.","journal-title":"Brain Res Rev"},{"key":"CITATION202","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fncel.2018.00329","volume":"12","author":"Fiebich BL","year":"2018","unstructured":"Fiebich BL, Batista CRA, Saliba SW, Yousif NM, de Oliveira ACP. Role of microglia TLRs in neurodegeneration. Front Cell Neurosci, 2018, 12:","journal-title":"Front Cell Neurosci"},{"key":"CITATION203","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuron.2009.08.039","volume":"64","author":"Lucin KM","year":"2009","unstructured":"Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron, 2009, 64: 110-122.","journal-title":"Neuron"},{"key":"CITATION204","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-2094-5-37","volume":"5","author":"Lee JW","year":"2008","unstructured":"Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, Oh KW, Hong JT. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflamm, 2008, 5:","journal-title":"J Neuroinflamm"},{"key":"CITATION205","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40035-021-00273-y","volume":"10","author":"Kim H","year":"2021","unstructured":"Kim H, Kim S, Shin SJ, Park YH, Nam Y, Kim C, Lee K. Gram-negative bacteria and their lipopolysaccharides in Alzheimer\u2019s disease: pathologic roles and therapeutic implications. Transl Neurodegener, 2021, 10:","journal-title":"Transl Neurodegener"},{"key":"CITATION206","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1742-2094-9-150","volume":"9","author":"Erickson MA","year":"2012","unstructured":"Erickson MA, Hartvigson PE, Morofuji Y, Owen JB, Butterfield DA, Banks WA. Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J Neuroinflamm, 2012, 9:","journal-title":"J Neuroinflamm"},{"key":"CITATION207","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bbi.2009.01.017","volume":"23","author":"Jaeger LB","year":"2009","unstructured":"Jaeger LB, Dohgu S, Sultana R, Lynch JL, Owen JB, Erickson MA, Shah GN. Lipopolysaccharide alters the blood-brain barrier transport of amyloid \u03b2 protein: a mechanism for inflammation in the progression of Alzheimer\u2019s disease. Brain Behav Immun, 2009, 23: 507-517.","journal-title":"Brain Behav Immun"},{"key":"CITATION208","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1742-2094-7-56","volume":"7","author":"Lee DC","year":"2010","unstructured":"Lee DC, Rizer J, Selenica MLB, Reid P, Kraft C, Johnson A, Blair L. LPS-induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J Neuroinflamm, 2010, 7:","journal-title":"J Neuroinflamm"},{"key":"CITATION209","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12974-016-0493-y","volume":"13","author":"Liu J","year":"2016","unstructured":"Liu J, Wang D, Li SQ, Yu Y, Ye RD. Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A. J Neuroinflamm, 2016, 13:","journal-title":"J Neuroinflamm"},{"key":"CITATION210","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nbt1097-1002","volume":"15","author":"Varley AW","year":"1997","unstructured":"Varley AW, Geiszler SM, Gaynor RB, Munford RS.  A two-component expression system that responds to inflammatory stimuli in vivo . Nat Biotechnol, 1997, 15: 1002-1006.","journal-title":"Nat Biotechnol"},{"key":"CITATION211","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41366-024-01590-8","volume":"48","author":"Visuthranukul C","year":"2024","unstructured":"Visuthranukul C, Sriswasdi S, Tepaamorndech S, Chamni S, Leelahavanichkul A, Joyjinda Y, Aksornkitti V. Enhancing gut microbiota and microbial function with inulin supplementation in children with obesity. Int J Obes, 2024, 48: 1696-1704.","journal-title":"Int J Obes"},{"key":"CITATION212","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3390\/nu13031017","volume":"13","author":"Wang B","year":"2021","unstructured":"Wang B, Kong Q, Cui S, Li X, Gu Z, Zhao J, Zhang H. Bifidobacterium adolescentis isolated from different hosts modifies the intestinal microbiota and displays differential metabolic and immunomodulatory properties in mice fed a high-fat diet. Nutrients, 2021, 13:","journal-title":"Nutrients"},{"key":"CITATION213","doi-asserted-by":"publisher","first-page":"1561047","DOI":"10.3389\/fsysb.2025.1561047","volume":"5","author":"Yassine F","year":"2025","unstructured":"Yassine F, Najm A, Bilen M. The role of probiotics, prebiotics, and synbiotics in the treatment of inflammatory bowel diseases: an overview of recent clinical trials. Front Syst Biol, 2025, 5:","journal-title":"Front Syst Biol"},{"key":"CITATION214","doi-asserted-by":"publisher","first-page":"e0024024","DOI":"10.1128\/cmr.00240-24","volume":"38","author":"Cho MY","year":"2025","unstructured":"Cho MY, Eom JH, Choi EM, Yang SJ, Lee D, Kim YY, Kim HS. Recent advances in therapeutic probiotics: insights from human trials. Clin Microbiol Rev, 2025, 38:","journal-title":"Clin Microbiol Rev"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/9FBC8930E75B452FA0CE8D7DBD13911A","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026130","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/9FBC8930E75B452FA0CE8D7DBD13911A","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:21:59Z","timestamp":1789971719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":214,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,24]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2026130","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}